Shah-Waardenburg syndrome and PCWH associated with SOX10 mutations: a case report and review of the literature.

[1]  J. Lupski,et al.  Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations , 2004, Nature Genetics.

[2]  J. Lupski,et al.  Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg–Hirschsprung disease: Phenotypes linked by SOX10 mutation , 2002, Annals of neurology.

[3]  I. Verma,et al.  SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism , 2002, Human Genetics.

[4]  M. Wegner,et al.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. , 2002, Genes & development.

[5]  M. Wegner,et al.  Development and degeneration of dorsal root ganglia in the absence of the HMG-domain transcription factor Sox10 , 2001, Mechanisms of Development.

[6]  O. Dubourg,et al.  Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. , 2001, Human molecular genetics.

[7]  P. Tam,et al.  Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome , 2001, Journal of medical genetics.

[8]  K. Nave,et al.  The transcription factor Sox10 is a key regulator of peripheral glial development. , 2001, Genes & development.

[9]  M. Wegner,et al.  Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. , 2000, Human molecular genetics.

[10]  M. Abu-Elmagd,et al.  Chick sox10, a transcription factor expressed in both early neural crest cells and central nervous system. , 2000, Brain research. Developmental brain research.

[11]  A. Munnich,et al.  Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. , 2000, American journal of human genetics.

[12]  M. Wegner,et al.  Protein Zero Gene Expression Is Regulated by the Glial Transcription Factor Sox10 , 2000, Molecular and Cellular Biology.

[13]  J. Lupski,et al.  Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation , 1999, Annals of neurology.

[14]  R. Agarwala,et al.  The Sox10(Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. , 1999, Genome research.

[15]  M. Wegner,et al.  Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Giovanni Romeo,et al.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease , 1998, Nature Genetics.

[17]  M. Wegner,et al.  Sox10, a Novel Transcriptional Modulator in Glial Cells , 1998, The Journal of Neuroscience.

[18]  W. Pavan,et al.  SOX10 mutation disrupts neural crest development in Dom Hirschsprung mouse model , 1998, Nature Genetics.

[19]  Jumi Lee,et al.  Influence of membrane lipid packing on T2‐weighted magnetic resonance images: Study of relaxation parameters in model membrane systems , 1996, Magnetic resonance in medicine.